Skip to main content
AkademIndex

Products

For developers

AkademBasesoonOpen API for the ecosystem
Latin
English
Article

MICROBIOLOGICAL CHARACTERISTICS OF THE DISEASE IN PATIENTS WITH CHRONIC PURULENT OTITIS MEDIA - URGENCH BRANCH OF TASHKENT MEDICAL ACADEMY

ESAMURATOV Aybek IbragimovichHead of Department Otorрhinolaryngology and Ophthalmology, Al-Khorazmiy St 28, Urgench City, UzbekistanKarimova Maksuda AhmedjanovnaPhD, Assistant, Department of Microbiology, Al-Khorazmiy St 28, Urgench City, UzbekistanSultanov Bekhzod OlimoyichAssistant, Department of Otorрhinolaryngology and Ophthalmology, Al-Khorazmiy St 28, Urgench City, UzbekistanOlimova Madinabonu MaxmudovnaStudent, Urgench Branch of the Tashkent Medical Academy, Al-Khorazmiy St 28, Urgench City, UzbekistanOrtiqov Bobomurod BaymamatovichPhD, Assistant, Tashkent Medical Academy, Farobiy st 2, Tashkent city, Uzbekistan
ABI

Abstract

<strong>Abstract</strong> The main goal of the research was to analyze the etiological and pathogenetic characteristics of the disease and to evaluate and scientifically substantiate the main factors of the type of microbe, growth pattern, environmental resistance in the development of the disease. According to our data, polyresistant strains of <em>S.aureus </em>and <em>Ps.aeruginosa </em>are the main cause of inflammation in the middle ear cavities. The microorganisms that grew at the highest level were <em>S. aureus </em>59.3%, 45.1% and 49.7% in all three groups, <em>S. epidermidis </em>16.3%, 38.2% and 32.1% respectively, and <em>Ps.aeruginosa </em>was observed in 24.1%, 16.7% and 18.2% of strains. In the obtained results, it was clearly determined that the incidence of <em>Pseudomonas aeruginosa </em>was 46.6% in mesotympanitis and 79.7% in epitympanitis. The same situation was observed in <em>Staphylococcus aureus </em>, in which it was 43.9% in mesotympanitis and 55.3% in epitympanitis. According to the results of determining the sensitivity of microbes to antibiotics, the change of <em>P.aeruginosa </em>strain isolation (IPM_10IU) 59.0%, to meropenem (MEM_10 IU) 71.0%, to ceftazidime (CAZ_10 IU) 69.0%, to amikacin (AMK-30 IU) 46.0%, to ciprofloxacin. (CIP-5 IU) was 78.0% and levofloxacin (LVX-5 IU) - 77.0%.

Topics

Identifiers

Citations and references

Cited by 00 references
Metrics — AkademScholar · Coming soon